1. Time-course gait pattern analysis in a rat model of foot drop induced by ventral root avulsion injury
   Shu-Yen Chan et al, 2022, Frontiers in Human Neuroscience CrossRef
2. Tocotrienols Ameliorate Neurodegeneration and Motor Deficits in the 6-OHDA-Induced Rat Model of Parkinsonism: Behavioural and Immunohistochemistry Analysis
   Mangala Kumari et al, 2021, Nutrients CrossRef
3. The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease
   Regev Landau et al, 2022, Disease Models & Mechanisms CrossRef
4. Increased Physiological GDNF Levels Have No Effect on Dopamine Neuron Protection and Restoration in a Proteasome Inhibition Mouse Model of Parkinson’s Disease
   Soophie Olfat et al, 2023, eneuro CrossRef
5. DA-9805, a Herbal Mixture, Restores Motor Manifestations in 6-Hydroxydopamine-induced Parkinson’s Disease Mouse Model by Regulating Striatal Dopamine and Acetylcholine Levels
   Eugene Huh et al, 2022, Frontiers in Pharmacology CrossRef
6. Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson’s disease
   Soung Hee Moon et al, 2022, Archives of Pharmacal Research CrossRef
7. Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment
   Xiao-Xiao Fu et al, 2022, Journal of Inflammation Research CrossRef
8. The Anti-Inflammatory Effect of Preventive Intervention with Ketogenic Diet Mediated by the Histone Acetylation of mGluR5 Promotor Region in Rat Parkinson’s Disease Model: A Dual-Tracer PET Study
   Yuankai Zhu et al, 2022, Parkinson's Disease CrossRef
9. Long-Term Motor Cortical Electrical Stimulation Ameliorates 6-Hydroxydopamine-Induced Motor Dysfunctions and Exerts Neuroprotective Effects in a Rat Model of Parkinson’s Disease
   Chi-Wei Kuo et al, 2022, Frontiers in Aging Neuroscience CrossRef
10. Vitamin D (VD3) Intensifies the Effects of Exercise and Prevents Alterations of Behavior, Brain Oxidative Stress, and Neuroinflammation, in Hemiparkinsonian Rats
    Roberta Oliveira da Costa et al, 2023, Neurochemical Research CrossRef
11. High-Frequency Repetitive Transcranial Magnetic Stimulation Regulates Astrocyte Activation by Modulating the Endocannabinoid System in Parkinson’s Disease
    Xin Kang et al, 2022, Molecular Neurobiology CrossRef
12. Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson’s Disease
    Zhongyuan Yu et al, 2018, Frontiers in Cellular Neuroscience CrossRef
13. Comparison between Tail Suspension Swing Test and Standard Rotation Test in Revealing Early Motor Behavioral Changes and Neurodegeneration in 6-OHDA Hemiparkinsonian Rats
    Ilaria Rosa et al, 2020, International Journal of Molecular Sciences CrossRef
14. Longitudinal assessment of motor function following the unilateral intrastriatal 6-hydroxydopamine lesion model in mice
    Xiuping Sun et al, 2022, Frontiers in Behavioral Neuroscience CrossRef
15. Prior exercise protects against oxidative stress and motor deficit in a rat model of Parkinson’s disease
    Leonam Oliver Durval Oliveira et al, 2020, Metabolic Brain Disease CrossRef
16. Lactiplantibacillus plantarum PS128 Alleviates Exaggerated Cortical Beta Oscillations and Motor Deficits in the 6-Hydroxydopamine Rat Model of Parkinson’s Disease
    Yi-Fan Ma et al, 2023, Probiotics and Antimicrobial Proteins CrossRef
17. Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease
    Bohye Kim et al, 2022, International Neurourology Journal CrossRef
18. Early Repetitive Transcranial Magnetic Stimulation Exerts Neuroprotective Effects and Improves Motor Functions in Hemiparkinsonian Rats
    Tsung-Hsun Hsieh et al, 2021, Neural Plasticity CrossRef
19. S‐adenosyl methionine improves motor co‐ordination with reduced oxidative stress, dopaminergic neuronal loss, and DNA methylation in the brain striatum of 6‐hydroxydopamine‐induced neurodegeneration in rats
    Sharmila Jalgaonkar et al, 2023, The Anatomical Record CrossRef
20. Glucagon-Like Peptide-1 Receptor Agonist Ameliorates 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Neurotoxicity Through Enhancing Mitophagy Flux and Reducing α-Synuclein and Oxidative Stress
    Tsu-Kung Lin et al, 2021, Frontiers in Molecular Neuroscience CrossRef
21. Unilateral Intrastriatal 6-Hydroxydopamine Lesion in Mice: A Closer Look into Non-Motor Phenotype and Glial Response
    Bárbara Mendes-Pinheiro et al, 2021, International Journal of Molecular Sciences CrossRef
22. Preventive Vitamin A Supplementation Improves Striatal Function in 6-Hydroxydopamine Hemiparkinsonian Rats
    Anaïs Marie et al, 2022, Frontiers in Nutrition CrossRef
23. IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson’s disease
    Rupinder Kaur Sodhi et al, 2021, NeuroToxicology CrossRef